India’s immunisation plan against Covid-19 may get bolstered soon with the rollout of locally manufactured single-dose Sputnik Light in September. Panacea Biotec, which had earlier partnered Russian Direct Investment Fund (RDIF), has submitted the dossier for seeking emergency-use authorisation to India’s drug regulator recently, sources told TOI. The vaccine, which will be available in limited quantities initially, is expected to be priced around Rs 750.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3AGjM9k
0 Comments